Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation

Completed · Not applicable

Conditions studied: Transplant Bone Disease

In brief

Bone is lost rapidly and fractures occur in 10-20% of patients who receive organ transplants within 2 years. The purpose of this study is to evaluate long-term effects of a pamidronate-vitamin D-calcium regimen on bone loss, fractures, and safety in recipients of kidney and heart transplants.

Key facts

Study ID

NCT00302627

Run by

Providence Health & Services

People needed

43

Starts

1999-01-01

Expected to finish

2002-11-01

Last updated by the study team

2018-08-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Kidney or heart transplant recipients

You may not qualify if…

• Hyperparathyroidism

Where it is running

• Providence Medical Research Center — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.